Pharma Cos. Get Bystolic Generic Delay Claims Tossed

By J. Edward Moreno (January 24, 2022, 5:55 PM EST) -- A New York federal judge dismissed claims brought against AbbVie and other pharmaceutical firms by direct purchasers including Walgreens and CVS as well as claims brought by end payers who accused the drugmakers of conspiring to keep generic forms of the blockbuster hypertension drug Bystolic off the market....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!